Carboplatin Treatment Options

A collection of 1685 research studies where Carboplatin is the interventional treatment. These studies are located in the United States . Carboplatin is used for conditions such as Non-Small Cell Lung Cancer, Ovarian Cancer and Lung Cancer.

Home

All Treatments

Carboplatin

Show Filters

Match to Clinical Trials

Access to cutting-edge treatments

Latest clinical trials

Find trials in your area

Start Matching

Filter by Age

Featured Trial

Healthy Participants Needed (Colonoscopy + Cancer Screening)

Recruiting

Earn $325 - $475 in electronic payment card compensation for your time and effort by participating in a clinical study to develop a blood test that may one day help screen for colon cancer. Take a quick quiz to see if you qualify.

Conditions:

Healthy

Healthy Volunteers

Healthy Subjects

Healthy Volunteer

Healthy Participants

Learn More

Featured Trial

Buy Retatrutide Online Through Celia

Recruiting

Retatrutide (formerly M25) is an investigational peptide being studied for its potential in supporting weight management and metabolic health. It acts on GLP-1, GIP, and glucagon receptors to influence appetite, energy regulation, and fat metabolism.

Conditions:

Healthy

Learn More

Featured Offer

Lose 20% of Body Weight With GLP-1's

Policy Lab has partnered with OnlineSemaglutide.org to offer trusted access to tirzepatide and other GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®.

Semaglutide and Tirzepatide are advanced GLP-1 medications designed to support weight management and metabolic health. They work by targeting GLP-1 receptors in the body, helping regulate appetite, improve blood sugar control, and support sustainable weight loss (up to 22% of body weight).

Get $50 off your first order using promo code: policy-lab-50

Conditions:

Overweight

Overweight and Obesity

Obesity

Weight Loss

Morbid Obesity

Learn More

Featured Trial

Birth Control Clinical Research Study

Recruiting

Living with obesity and looking for a birth control option that is right for you? Clinical trials are now enrolling women with a body mass index (BMI) of 30 or more in the area to help study a potential new progestin-only contraceptive patch. Participating in research studies can help advance birth control options. Don’t let financial stress hold you back. All study-related assessments, care, and study patch are available at no cost. You may also be reimbursed for study-related travel.

Conditions:

Obesity

Overweight

Overweight and Obesity

Learn More

HOT: HIPEC in Ovarian Cancer as Initial Treatment

NCT02124421

Active Not Recruiting

Community hospital based phase II (prospective randomized) study to evaluate the toxicity of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in newly diagnosed, otherwise untreated, advanced stage (stage III/IV) epithelial ovarian, fallopian tube, and primary peritoneal cancer.

Gender:

FEMALE

Ages:

Between 18 years and 80 years

Trial Updated:

11/18/2024

Locations: Mercy Medical Center, Baltimore, Maryland

Conditions: Stage III Ovarian Cancer, Stage IV Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma, Ovarian Carcinoma, Fallopian Tube Carcinoma

Learn More ›

An Investigational Immuno-therapy Trial of Nivolumab, or Nivolumab Plus Ipilimumab, or Nivolumab Plus Platinum-doublet Chemotherapy, Compared to Platinum Doublet Chemotherapy in Patients With Stage IV Non-Small Cell Lung Cancer (NSCLC)

NCT02477826

Completed

The purpose of this study is to show that Nivolumab, or Nivolumab plus Ipilimumab, or Nivolumab plus Platinum-Doublet Chemotherapy improves progression free survival and/or overall survival compared with chemotherapy in patients with advanced lung cancer.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

11/16/2024

Locations: Southern Cancer Center, Inc., Mobile, Alabama +289 locations

Southern Cancer Center, Inc., Mobile, Alabama

Local Institution - 0017, San Francisco, California

Local Institution - 0021, New Haven, Connecticut

Local Institution - 0001, Atlanta, Georgia

Local Institution - 0013, Marietta, Georgia

Local Institution - 0004, Lexington, Kentucky

Local Institution - 0115, Saint Louis, Missouri

Local Institution - 0005, Buffalo, New York

Local Institution - 0019, New York, New York

Local Institution - 0014, Cleveland, Ohio

Local Institution - 0009, Columbus, Ohio

Local Institution - 0007, Allentown, Pennsylvania

Local Institution - 0075, Langhorne, Pennsylvania

Local Institution - 0299, Philadelphia, Pennsylvania

Local Institution - 0012, Philadelphia, Pennsylvania

Local Institution - 0015, Sayre, Pennsylvania

Local Institution - 0008, Charleston, South Carolina

Local Institution - 0080, Greenville, South Carolina

Local Institution - 0010, Greenville, South Carolina

Local Institution - 0020, Nashville, Tennessee

Local Institution - 0306, Dallas, Texas

Local Institution - 0003, Dallas, Texas

Local Institution - 0102, Houston, Texas

Local Institution - 0011, Salt Lake City, Utah

Local Institution - 0074, Kennewick, Washington

Local Institution - 0170, Berazategui, Buenos Aires

Local Institution - 0171, Capital Federal, Buenos Aires

Local Institution - 0172, Ciudad Autonoma De Buenos Aire, Buenos Aires

Local Institution - 0176, Ciudad de Buenos Aires, Buenos Aires

Local Institution - 0296, Mar Del Plata, Buenos Aires

Local Institution - 0177, Viedma, RIO Negro

Local Institution - 0130, San Miguel de Tucuman, Tucuman

Local Institution - 0268, Cordoba, Not set

Local Institution - 0272, Córdoba, Not set

Local Institution - 0297, Córdoba, Not set

Local Institution - 0182, Garran, Australian Capital Territory

Local Institution - 0301, Blacktown, New South Wales

Local Institution - 0300, Gosford, New South Wales

Local Institution - 0045, Brisbane, Queensland

Local Institution - 0046, Elizabeth Vale, South Australia

Local Institution - 0043, Clayton, Victoria

Local Institution - 0042, Fitzroy, Victoria

Local Institution - 0180, Perth, Western Australia

Local Institution - 0040, Murdoch, Not set

Local Institution - 0183, North Tamworth, Not set

Local Institution - 0241, Graz, Not set

Local Institution - 0240, Vienna, Not set

Local Institution - 0239, Wels, Not set

Local Institution - 0121, Roeselare, West-Vlaanderen

Local Institution - 0030, Edegem, Not set

Local Institution - 0031, Gent, Not set

Local Institution - 0034, Gilly, Not set

Local Institution - 0117, Hasselt, Not set

Local Institution - 0033, Sint Niklaas, Not set

Local Institution - 0125, Salvador, Bahia

Local Institution - 0124, Ijui, RIO Grande DO SUL

Local Institution - 0123, Porto Alegre, Rio Grande Do Sul

Local Institution - 0127, Barretos, Sao Paulo

Local Institution - 0129, Rio De Janeiro, Not set

Local Institution - 0144, Sao Paulo, Not set

Local Institution - 0126, Sao Paulo, Not set

Local Institution - 0128, Sao Paulo, Not set

Local Institution - 0103, Edmonton, Alberta

Local Institution - 0290, St. John's, Newfoundland and Labrador

Local Institution - 0104, London, Ontario

Local Institution - 0122, Montreal, Quebec

Local Institution - 0106, Quebec City, Quebec

Local Institution - 0107, Rimouski, Quebec

Local Institution - 0291, Sherbrooke, Quebec

Local Institution - 0292, Trois-Rivieres, Quebec

Local Institution - 0302, Quebec, Not set

Local Institution - 0173, Santiago, Metropolitana

Local Institution - 0131, Santiago, Región Metropolitana De Santiago

Local Institution - 0174, Vina Del Mar, Valparaiso

Local Institution - 0380, Hefei, Anhui

Local Institution - 0313, Beijing, Beijing

Local Institution - 0315, Beijing, Beijing

Local Institution - 0316, Beijing, Beijing

Local Institution - 0314, Beijing, Beijing

Local Institution - 0365, Chongqing, Chongqing

Local Institution - 0364, Chongqing, Chongqing

Local Institution - 0378, Chongqing, Chongqing

Local Institution - 0322, Guangzhou, Guangdong

Local Institution - 0372, Guangzhou, Guangdong

Local Institution - 0319, Guanzhou, Guangdong

Local Institution - 0323, Haikou, Hainan

Local Institution - 0325, Haerbin, Heilongjiang

Local Institution - 0324, Zhengzhou, Henan

Local Institution - 0379, Zhengzhou, Henan

Local Institution - 0375, Wuhan, Hubei

Local Institution - 0362, Changsha, Hunan

Local Institution - 0347, Nanchang, Jiangxi

Local Institution - 0329, Changchun, Jilin

Local Institution - 0361, Changchun, Jilin

Local Institution - 0359, Shenyang, Liaoning

Local Institution - 0371, Xi'an, Shaanxi

Local Institution - 0333, Xi'an, Shan3xi

Local Institution - 0360, Qingdao, Shandong

Local Institution - 0334, Shanghai, Shanghai

Local Institution - 0376, Chengdu, Sichuan

Local Institution - 0373, Tianjin, Tianjin

Local Institution - 0340, Urumqi, Xinjiang

Local Institution - 0343, Hangzhou, Zhejiang

Local Institution - 0370, Hangzhou, Zhejiang

Local Institution - 0342, Hangzhou, Zhejiang

Local Institution - 0328, Changsha, Not set

Local Institution - 0341, Hangzhou, Not set

Local Institution - 0345, Kunming, Not set

Local Institution - 0336, Shanghai, Not set

Local Institution - 0337, Shanghai, Not set

Local Institution - 0374, Shantou, Not set

Local Institution - 0273, Pereira, Risaralda

Local Institution - 0237, Bogota, Not set

Local Institution - 0238, Bogota, Not set

Local Institution - 0282, Medellin, Not set

Local Institution - 0112, Hradec Kralove, Not set

Local Institution - 0113, Olomouc, Not set

Local Institution - 0111, Praha 4, Not set

Local Institution - 0232, Pribram, Not set

Local Institution - 0270, Oulu, Not set

Local Institution - 0271, Turku, Not set

Local Institution - 0222, Bron, Rhône

Local Institution - 0216, ANGERS Cedex 2, Not set

Local Institution - 0229, Besançon Cedex, Not set

Local Institution - 0283, Caen, Not set

Local Institution - 0218, Creteil, Not set

Local Institution - 0228, Limoges, Not set

Local Institution - 0215, Marseille Cedex 20, Not set

Local Institution - 0230, Paris, Not set

Local Institution - 0227, Pessac, Not set

Local Institution - 0223, Rennes, Not set

Local Institution - 0225, Rouen, Not set

Local Institution - 0221, Saint Priest En Jarez, Not set

Local Institution - 0217, Saint-herblain Cedex, Not set

Local Institution - 0224, Strasbourg, Not set

Local Institution - 0226, Toulon, Not set

Local Institution - 0231, Magdeburg, Sachsen-Anhalt

Local Institution - 0213, Bad Berka, Not set

Local Institution - 0208, Berlin, Not set

Local Institution - 0205, Essen, Not set

Local Institution - 0210, Frankfurt, Not set

Local Institution - 0211, Gera, Not set

Local Institution - 0203, Grosshansdorf, Not set

Local Institution - 0209, Halle, Not set

Local Institution - 0202, Heidelberg, Not set

Local Institution - 0214, Hemer, Not set

Local Institution - 0206, Immenstadt, Not set

Local Institution - 0204, Muenchen, Not set

Local Institution - 0201, Stuttgart, Not set

Local Institution - 0212, Wiesbaden, Not set

Local Institution - 0094, Athens, Attikí

Local Institution - 0095, Heraklion, Not set

Local Institution - 0190, Neo Faliro, Not set

Local Institution - 0101, Thessaloniki, Not set

Local Institution - 0025, Budapest, Not set

Local Institution - 0024, Budapest, Not set

Local Institution - 0026, Matrahaza, Not set

Local Institution - 0054, Dublin 8, Dublin

Local Institution - 0053, Beaumont, Not set

Local Institution - 0055, Galway, Not set

Local Institution - 0100, Limerick, Not set

Local Institution - 0187, Jerusalem, Not set

Local Institution - 0186, Kfar-saba, Not set

Local Institution - 0185, Petach Tikva, Not set

Local Institution - 0184, Tel-hashomer, Not set

Local Institution - 0188, Zerifin, Not set

Local Institution - 0083, Milan, Lombardia

Azienda Ospedaliera Moscati, Avellino, Not set

Local Institution - 0179, Bergamo, Not set

IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola, Bologna, Not set

Local Institution - 0084, Livorno, Not set

Policlinico G. Martino, Messina, Not set

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Not set

Istituto Nazionale Tumori Fondazione Pascale, Napoli, Not set

Local Institution - 0087, Perugia, Not set

Ospedale Santa Maria delle Croci, Ravenna, Not set

Ifo-Istituto Regina Elena, Roma, Not set

Local Institution - 0089, Roma, Not set

Local Institution - 0085, Terni, Not set

Local Institution - 0153, Nagoya-shi, Aichi

Local Institution - 0152, Nagoya, Aichi

Local Institution - 0148, Kashiwa-shi, Chiba

Local Institution - 0159, Matsuyama, Ehime

Local Institution - 0160, Fukuoka-shi, Fukuoka

Local Institution - 0259, Kurume-shi, Fukuoka

Local Institution - 0255, Ota-shi, Gunma

Local Institution - 0258, Hiroshima-shi, Hiroshima

Local Institution - 0163, Sapporo-shi, Hokkaido

Local Institution - 0253, Sapporo-shi, Hokkaido

Local Institution - 0252, Akashi-shi, Hyogo

Local Institution - 0156, Kobe-shi, Hyogo

Local Institution - 0146, Kanazawa-shi, Ishikawa

Local Institution - 0161, Yokohama-shi, Kanagawa

Local Institution - 0150, Yokohama-Shi, Kanagawa

Local Institution - 0275, Natori-shi, Miyagi

Local Institution - 0254, Sendai-shi, Miyagi

Local Institution - 0145, Sendai-shi, Miyagi

Local Institution - 0164, Niigata-shi, Niigata

Local Institution - 0158, Kurashiki-shi, Okayama

Local Institution - 0155, Hirakata-shi, Osaka

Local Institution - 0154, Osaka-shi, Osaka

Local Institution - 0251, Osakasayama-shi, Osaka

Local Institution - 0257, Takatsuki-shi, Osaka

Local Institution - 0353, Hidaka-shi, Saitama

Local Institution - 0256, Kitaadachi-gun, Saitama

Local Institution - 0151, Sunto-gun, Shizuoka

Local Institution - 0147, Chuo-ku, Tokyo

Local Institution - 0149, Koto-ku, Tokyo

Local Institution - 0278, Shinjuku-ku, Tokyo

Local Institution - 0157, Wakayama-shi, Wakayama

Local Institution - 0354, Ube-shi, Yamaguchi

Local Institution - 0260, Chiba, Not set

Local Institution - 0165, Okayama, Not set

Local Institution - 0162, Tokyo, Not set

Local Institution - 0136, Seongnam-si, Kyǒnggi-do

Local Institution - 0249, Cheongju-si, Not set

Local Institution - 0133, Gangnam-gu, Not set

Local Institution - 0132, Seoul, Not set

Local Institution - 0135, Seoul, Not set

Local Institution - 0287, Beirut, Not set

Local Institution - 0286, Beirut, Not set

Local Institution - 0196, Df, Distrito Federal

Local Institution - 0193, Mexico, Distrito Federal

Local Institution - 0198, Cuautitlan, Estado DE Mexico

Local Institution - 0197, Guadalajara, Jalisco

Local Institution - 0191, Zapopan, Jalisco

Local Institution - 0267, Morelia, Michoacan

Local Institution - 0277, Monterrey, Nuevo Leon

Local Institution - 0303, Merida, Yucatán

Local Institution - 0192, Chihuahua, Not set

Local Institution - 0195, San Luis Potosi, Not set

Local Institution - 0236, San Luis Potosi, Not set

Local Institution - 0194, Toluca, Not set

Local Institution - 0036, Amsterdam, Not set

Local Institution - 0189, Amsterdam, Not set

Local Institution - 0169, Breda, Not set

Local Institution - 0037, Rotterdam, Not set

Local Institution - 0039, Veldhoven, Not set

Local Institution - 0262, Lima, Not set

Local Institution - 0263, Lima, Not set

Local Institution - 0350, Lima, Not set

Local Institution - 0261, Lima, Not set

Local Institution - 0351, Lima, Not set

Local Institution - 0060, Bydgoszcz, Not set

Local Institution - 0058, Gdansk, Not set

Local Institution - 0063, Gdynia, Not set

Local Institution - 0072, Gliwice, Not set

Local Institution - 0057, Lodz, Not set

Local Institution - 0059, Warszawa, Not set

Local Institution - 0070, Wroclaw, Not set

Local Institution - 0167, Craiova, Not set

Local Institution - 0250, Floresti, Not set

Local Institution - 0166, Romania, Not set

Local Institution - 0284, Sector 2, Not set

Local Institution - 0137, Chelyabinsk, Not set

Local Institution - 0142, Kazan, Not set

Local Institution - 0022, Moscow, Not set

Local Institution - 0049, Saint-Petersburg, Not set

Local Institution - 0028, St. Petersburg, Not set

Local Institution - 0027, St. Petersburg, Not set

Local Institution - 0143, Ufa, Not set

Local Institution - 0264, Pretoria, Gauteng

Local Institution - 0234, Sandton, Gauteng

Local Institution - 0233, Saxonwold, Johannesburg, Gauteng

Local Institution - 0305, Vereeniging, Not set

Local Institution - 0064, Majadahonda, Madrid

Local Institution - 0066, Barcelona, Not set

Local Institution - 0067, Barcelona, Not set

Local Institution - 0065, Madrid, Not set

Local Institution - 0069, Sevilla, Not set

Local Institution - 0068, Valencia, Not set

Local Institution - 0243, Basel, Not set

Local Institution - 0246, Chur, Not set

Local Institution - 0244, Lausanne, Not set

Local Institution - 0245, Winterthur, Not set

Local Institution - 0139, Taichung, Not set

Local Institution - 0138, Taipei, Not set

Local Institution - 0140, Taipei, Not set

Local Institution - 0310, Taipei, Not set

Local Institution - 0141, Taoyuan city, Not set

Local Institution - 0266, Middlesborough, Cleveland

Local Institution - 0098, London, Greater London

Local Institution - 0099, Southampton, Hampshire

Local Institution - 0118, Leicester, Leicestershire

Local Institution - 0265, Birmingham, Not set

Local Institution - 0051, Cambridgeshire, Not set

Local Institution - 0109, Edinburgh, Not set

Local Institution - 0097, London, Not set

Local Institution - 0050, London, Not set

Local Institution - 0119, Surrey, Not set

Conditions: Non-Small Cell Lung Cancer

Learn More ›

Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK-001/ENGOT-ov43/GOG-3036)

NCT03740165

Active Not Recruiting

The purpose of this study is to assess the efficacy and safety of treatment with carboplatin/paclitaxel\* PLUS pembrolizumab (MK-3475) and maintenance olaparib (MK-7339) in women with epithelial ovarian cancer (EOC), fallopian tube cancer, or primary peritoneal cancer. The primary study hypotheses are that the combination of pembrolizumab plus carboplatin/paclitaxel\* followed by continued pembrolizumab and maintenance olaparib is superior to carboplatin/paclitaxel alone with respect to Progres... Read More

Gender:

FEMALE

Ages:

18 years and above

Trial Updated:

11/15/2024

Locations: University of Alabama at Birmingham (UAB) ( Site 0036), Birmingham, Alabama +226 locations

University of Alabama at Birmingham (UAB) ( Site 0036), Birmingham, Alabama

University of Arizona Cancer Center ( Site 0074), Tucson, Arizona

Disney Family Cancer Center ( Site 0042), Burbank, California

Kaiser Permanente Oncology Clinical Trial -Oakland ( Site 0077), Oakland, California

Kaiser Permanente Oncology Clinical Trials-Roseville ( Site 0084), Roseville, California

Kaiser Permanente Oncology Clinical Trials-Sacramento ( Site 0083), Sacramento, California

Kaiser Permanente Oncology Clinical Trial - San Francisco ( Site 0078), San Francisco, California

Kaiser Permanente Oncology Clinical Trial - Santa Clara ( Site 0079), Santa Clara, California

Kaiser Permanente N. CA Regional Oncology Clinical Trials ( Site 0008), Vallejo, California

Kaiser Permanente Oncology Clinical Trial - Walnut Creek ( Site 0080), Walnut Creek, California

Smilow Cancer Center at Yale-New Haven ( Site 0057), New Haven, Connecticut

Sarasota Memorial Hospital ( Site 0023), Sarasota, Florida

Emory School of Medicine ( Site 0053), Atlanta, Georgia

Northeast Georgia Medical Center ( Site 0029), Gainesville, Georgia

Memorial Health University Medical Center ( Site 0011), Savannah, Georgia

Rush University Medical Center ( Site 0019), Chicago, Illinois

University of Chicago ( Site 0049), Chicago, Illinois

Dr. Sudarshan K. Sharma, LTD ( Site 0061), Hinsdale, Illinois

Saint Vincent Hospital and Health Center ( Site 0012), Indianapolis, Indiana

University of Iowa Hospital and Clinics ( Site 0005), Iowa City, Iowa

University of Kentucky ( Site 0045), Lexington, Kentucky

Weinberg Cancer Institute at Franklin Square ( Site 0035), Baltimore, Maryland

Saint Dominic - Jackson Memorial Hospital ( Site 0072), Jackson, Mississippi

Washington University - School of Medicine ( Site 0062), Saint Louis, Missouri

Nebraska Methodist Hospital ( Site 0063), Omaha, Nebraska

Dartmouth Hitchcock Medical Center ( Site 0024), Lebanon, New Hampshire

MD Anderson Cancer Center at Cooper ( Site 0067), Camden, New Jersey

Holy Name Medical Center ( Site 0037), Teaneck, New Jersey

Northwell Health- Monter Cancer Center ( Site 0075), Lake Success, New York

Sanford Roger Maris Cancer Center ( Site 0082), Fargo, North Dakota

Miami Valley Hospital [Dayton, OH] ( Site 0073), Centerville, Ohio

Oncology/Hematology Care Clinical Trials, LLC ( Site 8001), Cincinnati, Ohio

The Bing Cancer Center ( Site 0044), Columbus, Ohio

OSU Wexner Medical Center ( Site 0076), Hilliard, Ohio

Women and Infants Hospital [Providence, RI] ( Site 0039), Providence, Rhode Island

Sanford Gynecology Oncology ( Site 0004), Sioux Falls, South Dakota

Texas Oncology, P.A. - Bedford ( Site 8005), Bedford, Texas

Texas Oncology-Dallas Presbyterian Hospital ( Site 8004), Dallas, Texas

Parkland Hospital ( Site 0081), Dallas, Texas

UT Southwestern Medical Center ( Site 0046), Dallas, Texas

Texas Oncology, P.A. Texas Oncology-Tyler ( Site 8006), Tyler, Texas

Virginia Cancer Specialists, PC ( Site 8003), Gainesville, Virginia

MEDICAL COLLEGE OF WISCONSIN ( Site 0064), Milwaukee, Wisconsin

St George Hospital ( Site 2207), Kogarah, New South Wales

Cairns and Hinterland Hospital and Health Service ( Site 2201), Cairns, Queensland

Ballarat Health Services ( Site 2202), Ballarat, Victoria

Monash Health ( Site 2204), Clayton, Victoria

Sunshine Hospital. ( Site 2205), St Albans, Victoria

Imelda Ziekenhuis Bonheiden ( Site 0301), Bonheiden, Antwerpen

UZ Leuven Campus Gasthuisberg ( Site 0306), Leuven, Antwerpen

Cliniques Universitaires Saint-Luc ( Site 0312), Brussels, Bruxelles-Capitale, Region De

Grand Hopital de Charleroi ( Site 0302), Charleroi, Hainaut

CHU de Liege ( Site 0310), Liège, Liege

Jessa Ziekenhuis ( Site 0309), Hasselt, Limburg

Centre Hospitalier de l'Ardenne ( Site 0303), Libramont, Luxembourg

AZ Maria Middelares Gent ( Site 0300), Gent, Oost-Vlaanderen

UZ Gent ( Site 0307), Gent, Oost-Vlaanderen

Instituto do Cancer do Ceara ( Site 2707), Fortaleza, Ceara

Hospital Araujo Jorge Associacao de Combate ao Cancer de Goias ( Site 2708), Goiania, Goias

Hospital Erasto Gaertner ( Site 2716), Curitiba, Parana

Hospital de Caridade de Ijui ( Site 2712), Ijui, Rio Grande Do Sul

Hospital Bruno Born ( Site 2704), Lajeado, Rio Grande Do Sul

Hospital Nossa Senhora Da Conceicao ( Site 2703), Porto Alegre, Rio Grande Do Sul

Instituto Nacional de Cancer Hospital do Cancer II ( Site 2700), Rio de Janeiro, Not set

Instituto do Cancer do Estado de Sao Paulo - ICESP ( Site 2714), Sao Paulo, Not set

Clinica de Pesquisas e Ctro de Estudos Onc. Ginecol. e Mamaria Ltda ( Site 2706), Sao Paulo, Not set

Real e Benemerita Associacao Portuguesa de Beneficencia ( Site 2710), Sao Paulo, Not set

Tom Baker Cancer Centre ( Site 0200), Calgary, Alberta

Kingston Health Sciences Centre ( Site 0207), Kingston, Ontario

The Credit Valley Hospital ( Site 0206), Mississauga, Ontario

Princess Margaret Hospital.. ( Site 0202), Toronto, Ontario

CIUSSS du Saguenay-Lac-St-Jean ( Site 0218), Chicoutimi, Quebec

CIUSSS de l Est de L Ile de Montreal - Hopital Maisonneuve-Rosemont ( Site 0219), Montreal, Quebec

Centre Hospitalier de l Universite de Montreal - CHUM ( Site 0208), Montreal, Quebec

Royal Victoria Hospital McGill University Health Centre ( Site 0211), Montreal, Quebec

Centro Investigación del Cáncer James Lind ( Site 2810), Temuco, Araucania

Centro de Investigacion y desarrollo Oncologico SpA - CIDO SpA ( Site 2808), Temuco, Araucania

Fundacion Arturo Lopez Perez FALP ( Site 2800), Santiago, Region M. De Santiago

Sociedad Oncovida S.A. ( Site 2807), Santiago, Region M. De Santiago

Iram Cancer Research ( Site 2809), Santiago, Region M. De Santiago

Pontificia Universidad Catolica de Chile ( Site 2805), Santiago, Region M. De Santiago

Oncocentro ( Site 2801), Vina del Mar, Valparaiso

Centro Oncologico Antofagasta ( Site 2804), Antofagasta, Not set

Biomelab S A S ( Site 2900), Barranquilla, Atlantico

Sociedad de Oncología Y Hematología del Cesar S.A.S. ( Site 2913), Valledupar, Cesar

Oncomedica S.A. ( Site 2911), Monteria, Cordoba

Instituto Nacional de Cancerologia E.S.E ( Site 2910), Bogota, Distrito Capital De Bogota

Clinica Colsanitas S.A. Sede Clinica Universitaria Colombia ( Site 2912), Bogota, Distrito Capital De Bogota

Centro Medico Imbanaco de Cali S.A ( Site 2909), Cali, Valle Del Cauca

Hemato Oncologos S.A. ( Site 2906), Cali, Valle Del Cauca

Fakultni nemocnice Brno ( Site 0404), Brno, Brno-mesto

Fakultni nemocnice Ostrava ( Site 0403), Ostrava-Poruba, Moravskoslezsky Kraj

Vseobecna fakultni nemocnice v Praze ( Site 0400), Praha, Praha, Hlavni Mesto

Nemocnice Na Bulovce ( Site 0401), Praha, Praha, Hlavni Mesto

Fakultni nemocnice Olomouc ( Site 0402), Olomouc, Not set

Hopital Prive Jean Mermoz ( Site 0607), Lyon, Auvergne

Centre Paul Strauss ( Site 0615), Strasbourg, Bas-Rhin

Hopital de la Timone ( Site 0617), Marseille, Bouches-du-Rhone

CHU de Brest -Site Hopital Morvan ( Site 0616), Brest, Bretagne

Institut de Cancerologie du Gard - CHU Caremeau ( Site 0610), Nimes, Gard

Institut de Cancerologie Lucien Neuwirth ( Site 0613), Saint-Priest-en-Jarez, Loire

Centre D Oncologie de Gentilly ( Site 0609), Nancy, Meurthe-et-Moselle

Institut Gustave Roussy ( Site 0600), Villejuif, Val-de-Marne

Hopital Tenon ( Site 0612), Paris, Not set

Marienhospital Stuttgart Vincenz von Paul Kliniken gGmbH ( Site 0707), Stuttgart, Baden-Wurttemberg

Klinikum Rechts der Isar. Technischen Universitaet Muenchen ( Site 0710), Muenchen, Bayern

Uniklinik RWTH Aachen ( Site 0718), Aachen, Nordrhein-Westfalen

Gynaekologisches Zentrum ( Site 0712), Bonn, Nordrhein-Westfalen

Klinikum Dortmund gGmbH ( Site 0717), Dortmund, Nordrhein-Westfalen

Universitaetsklinikum Duesseldorf ( Site 0704), Duesseldorf, Nordrhein-Westfalen

HELIOS Klinikum Krefeld ( Site 0715), Krefeld, Nordrhein-Westfalen

Universitaetsklinikum Muenster ( Site 0720), Muenster, Nordrhein-Westfalen

Caritas Klinikum Saarbruecken St. Theresia ( Site 0702), Saarbruecken, Saarland

Klinikum Chemnitz gGmbH ( Site 0711), Chemnitz, Sachsen

Staedtisches Krankenhaus Kiel GmbH ( Site 0709), Kiel, Schleswig-Holstein

Charite Campus Virchow-Klinikum - CVK ( Site 0700), Berlin, Not set

Pecsi Tudomanyegyetem Klinikai Kozpont ( Site 0805), Pecs, Baranya

Borsod-Abauj-Zemplen Megyei Korhaz es Egyetemi Oktato Korhaz ( Site 0802), Miskolc, Borsod-Abauj-Zemplen

Orszagos Onkologiai Intezet ( Site 0800), Budapest, Not set

Uzsoki Utcai Korhaz ( Site 0803), Budapest, Not set

Debreceni Egyetem Klinikai Kozpont ( Site 0801), Debrecen, Not set

Soroka Medical Center ( Site 1006), Beer-Sheva, Not set

Hillel Yaffe Medical Center ( Site 1011), Hadera, Not set

Carmel Medical Center ( Site 1007), Haifa, Not set

Rambam Medical Center ( Site 1002), Haifa, Not set

Edith Wolfson Medical Center ( Site 1003), Holon, Not set

Shaare Zedek Medical Center ( Site 1005), Jerusalem, Not set

Rabin Medical Center ( Site 1004), Petah Tikva, Not set

Chaim Sheba Medical Center ( Site 1000), Ramat Gan, Not set

Sourasky Medical Center ( Site 1001), Tel Aviv, Not set

IRCCS Giovanni Paolo II. Ospedale Oncologico ( Site 1108), Bari, Abruzzo

Istituto Europeo di Oncologia ( Site 1100), Milano, Lombardia

A.O.U. Citta della Salute e della Scienza di Torino ( Site 1104), Torino, Piemonte

Istituto Oncologico Veneto IRCCS ( Site 1113), Padova, Veneto

Sacro Cuore di Gesu Fatebenefratelli ( Site 1112), Benevento, Not set

Ospedale Cannizzaro ( Site 1110), Catania, Not set

ASST Lecco. Ospedale A. Manzoni ( Site 1101), Lecco, Not set

Fondazione IRCCS Istituto Nazionale dei Tumori di Milano ( Site 1115), Milano, Not set

A.O.U. Federico II di Napoli ( Site 1107), Napoli, Not set

Azienda Ospedaliera Policlinico Umberto I ( Site 1111), Roma, Not set

Policlinico Universitario Gemelli ( Site 1105), Roma, Not set

Presidio Ospedaliero Santa Chiara ( Site 1109), Trento, Not set

A.O. Univ. S. M. della Misericordia ( Site 1114), Udine, Not set

National Cancer Center Hospital East ( Site 2602), Kashiwa, Chiba

National Hospital Organization Shikoku Cancer Center ( Site 2601), Matsuyama, Ehime

Ehime University Hospital ( Site 2600), Toon, Ehime

Gunma Prefectural Cancer Center ( Site 2609), Ota, Gunma

Hokkaido University Hospital ( Site 2607), Sapporo, Hokkaido

Iwate Medical University Hospital ( Site 2606), Shiwa-gun, Iwate

St. Marianna University School of Medicine Hospital ( Site 2613), Kawasaki, Kanagawa

University of the Ryukyus Hospital ( Site 2616), Nakagami-gun, Okinawa

Saitama Medical University International Medical Center ( Site 2604), Hidaka, Saitama

Saitama Cancer Center ( Site 2614), Kitaadachi-gun, Saitama

National Defense Medical College Hospital ( Site 2608), Tokorozawa, Saitama

Kyorin University Hospital ( Site 2610), Mitaka, Tokyo

Kagoshima City Hospital ( Site 2612), Kagoshima, Not set

Niigata Cancer Center Hospital ( Site 2618), Niigata, Not set

Osaka International Cancer Institute ( Site 2617), Osaka, Not set

National Cancer Center Hospital ( Site 2605), Tokyo, Not set

Seoul National University Bundang Hospital ( Site 2404), Seongnam-si, Kyonggi-do

Seoul National University Hospital ( Site 2403), Seoul, Not set

Severance Hospital Yonsei University Health System ( Site 2400), Seoul, Not set

Asan Medical Center ( Site 2402), Seoul, Not set

Samsung Medical Center ( Site 2401), Seoul, Not set

Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy w Warszawie (, Warszawa, Mazowieckie

Bialostockie Centrum Onkologii ( Site 1412), Bialystok, Podlaskie

Szpitale Pomorskie Sp. z o.o. ( Site 1407), Gdynia, Pomorskie

Narodowy Instytut Onkologii - Oddzial w Gliwicach ( Site 1406), Gliwice, Slaskie

Swietokrzyskie Centrum Onkologii SPZOZ ( Site 1410), Kielce, Swietokrzyskie

Szpital Kliniczny im. Przemienienia Panskiego Uniwersytetu Medycznego im. K. Marcinkowskiego w Pozna, Poznan, Wielkopolskie

Arkhangelsk Clinical Oncological Dispensary ( Site 1508), Arkhangelsk, Arkhangel Skaya Oblast

Republican Clinical Oncology Dispensary of Republic of Bashkortostan ( Site 1507), Ufa, Baskortostan, Respublika

A. Tsyb Medical Radiological Research Center ( Site 1513), Obninsk, Kaluzskaja Oblast

FSBI National Medical Oncology Research Center n.a. N.N. Blokhina ( Site 1500), Moscow, Moskva

FSCC of Special Types of Med. Care and Technologies ( Site 1503), Moscow, Moskva

Medical Rehabilitation Center ( Site 1502), Moscow, Moskva

City Clinical Oncology Center ( Site 1505), Saint Petersburg, Sankt-Peterburg

National Medical Research Center of Oncology N.A. N.N. Petrov ( Site 1504), Saint-Petersburg, Sankt-Peterburg

Republican Clinical Oncology Dispensary of Tatarstan MoH ( Site 1509), Kazan, Tatarstan, Respublika

Cancer Care Langenhoven Drive Oncology Centre ( Site 1701), Port Elizabeth, Eastern Cape

Groote Schuur Hospital ( Site 1704), Cape Town, Gauteng

Wits Clinical Research ( Site 1702), Johannesburg, Gauteng

Department of Medical Oncology ( Site 1703), Pretoria, Gauteng

Curo Oncology ( Site 1710), Pretoria, Gauteng

Wilgers Oncology Centre ( Site 1705), Pretoria, Gauteng

Little Company of Mary Hospital ( Site 1700), Pretoria, Gauteng

Sandton Oncology Medical Group PTY LTD ( Site 1712), Sandton, Gauteng

The Oncology Centre ( Site 1709), Durban, Kwazulu-Natal

Cancercare ( Site 1706), Cape Town, Western Cape

Outeniqua Cancercare Oncology Unit ( Site 1708), George, Western Cape

Cape Town Oncology Trials Pty Ltd ( Site 1707), Kraaifontein, Western Cape

Instituto Catalan de Oncologia ICO - Hospital Duran i Reynals ( Site 1603), Hospitalet de Llobregat, Barcelona

Xarxa Assistencial Universitaria Manresa ( Site 1605), Manresa, Barcelona

Hospital de Terrassa ( Site 1606), Terrassa, Barcelona

Hospital Universitario de Donostia ( Site 1602), Donostia, Gipuzkoa

Complejo Hospitalario Universitario A Coruna. CHUAC ( Site 1608), A Coruna, La Coruna

Instituto Valenciano de Oncologia ( Site 1601), Valencia, Valenciana, Comunitat

Hospital General Universitario de Valencia ( Site 1610), Valencia, Valenciana, Comunitat

Hospital Provincial San Pedro de Alcantara ( Site 1607), Caceres, Not set

Hospital Universitario Lucus Augusti ( Site 1609), Lugo, Not set

Clinica Universitaria de Navarra ( Site 1600), Madrid, Not set

Hospital Universitario Virgen del Rocio ( Site 1604), Sevilla, Not set

Changhua Christian Hospital ( Site 2507), Changhua, Not set

China Medical University Hospital ( Site 2506), Taichung, Not set

Taichung Veterans General Hospital ( Site 2510), Taichung, Not set

National Cheng Kung University Hospital ( Site 2508), Tainan, Not set

National Taiwan University Hospital ( Site 2502), Taipei, Not set

MacKay Memorial Hospital ( Site 2500), Taipei, Not set

Taipei Veterans General Hospital ( Site 2503), Taipei, Not set

Linkou Chang Gung Memorial Hospital ( Site 2501), Taoyuan, Not set

Istanbul Acibadem University Atakent Hospital ( Site 1902), Kucukcekmece, Istanbul

Etlik Zubeyde Hanim Kadin Hastaliklari Egitim ve Arastirma Hastanesi ( Site 1903), Ankara, Not set

Ankara UTF Cebeci Arastırma ve Uygulama Hastanesi ( Site 1905), Ankara, Not set

Akdeniz Universitesi Tıp Fakultesi ( Site 1901), Antalya, Not set

Uludag Universitesi Tip Fakultesi ( Site 1904), Bursa, Not set

Istanbul Universitesi Istanbul Tip Fakultesi ( Site 1900), Istanbul, Not set

Bakirkoy Sadi Konuk Egitim ve Arastirma Hastanesi ( Site 1907), Istanbul, Not set

Medipol Universite Hastanesi ( Site 1909), Istanbul, Not set

Sakarya Universitesi Tip Fakultesi Hastanesi ( Site 1906), Sakarya, Not set

MI Precarpathian Clinical Oncology Center ( Site 2181), Ivano-Frankivsk, Ivano-Frankivska Oblast

Grigoriev Institute for medical Radiology NAMS of Ukraine ( Site 2180), Kharkiv, Kharkivska Oblast

Municipal non-profit Enterprise Khmelnytskyi Regional Antitu-Gynecological Oncology department, Poli, Khmelnytskyi, Khmelnytska Oblast

Lviv State Oncology Regional Treatment and Diagnostic Center ( Site 2170), Lviv, Lvivska Oblast

MI Odessa Regional Oncological Centre ( Site 2121), Odesa, Odeska Oblast

RMI - Sumy Regional Clinical Oncology Dispensary ( Site 2191), Sumy, Sumska Oblast

Central City Clinical Hospital ( Site 2150), Uzhgorod, Zakarpatska Oblast

Kyiv City Clinical Oncological Center ( Site 2140), Kyiv, Not set

Conditions: Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Neoplasms

Learn More ›

Study of Pembrolizumab (MK-3475) Subcutaneous (SC) Versus Pembrolizumab Intravenous (IV) Administered With Platinum Doublet Chemotherapy in Participants With Metastatic Squamous or Nonsquamous Non-Small Cell Lung Cancer (NSCLC) (MK-3475-A86)

NCT04956692

Active Not Recruiting

The purpose of this study is to evaluate pembrolizumab (MK-3475) subcutaneous (SC) administration as the first-line therapy in the treatment of metastatic squamous and nonsquamous NSCLC by assessing the pharmacokinetics (PK), safety, and efficacy of pembrolizumab SC injection in combination with standard-of-care chemotherapy. The primary hypothesis of the study is Pembrolizumab SC is noninferior to pembrolizumab intravenous (IV) for Cycle 1 Area Under Curve (AUC) and Cycle 6 minimal concentratio... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

11/14/2024

Locations: St. Bernards Medical Center ( Site 0103), Jonesboro, Arkansas +125 locations

St. Bernards Medical Center ( Site 0103), Jonesboro, Arkansas

St Joseph Heritage Healthcare-Oncology ( Site 0102), Fullerton, California

Cancer Blood and Specialty Clinic ( Site 0105), Los Alamitos, California

PIH Health Hematology Medical Oncology ( Site 0106), Whittier, California

Holy Cross Hospital ( Site 0017), Fort Lauderdale, Florida

Memorial Regional Hospital-Memorial Cancer Institute ( Site 0104), Hollywood, Florida

Advent Health ( Site 0013), Orlando, Florida

Fort Wayne Medical Oncology and Hematology ( Site 0101), Fort Wayne, Indiana

Baptist Health Lexington ( Site 0099), Lexington, Kentucky

St Luke's Hospital - Kansas City ( Site 0033), Kansas City, Missouri

St. Vincent Frontier Cancer Center ( Site 0058), Billings, Montana

Montefiore Medical Center [Bronx, NY] ( Site 0040), Bronx, New York

The University of Tennessee Medical Center ( Site 0050), Knoxville, Tennessee

Tennessee Oncology ( Site 0051), Nashville, Tennessee

Oncology Consultants, PA ( Site 0052), Houston, Texas

Millennium Physicians - Oncology ( Site 0097), Houston, Texas

Oncology & Hematology Assoc. SW Virginia, Inc., DBA Blue Ridge Cancer Care ( Site 0100), Blacksburg, Virginia

West Virginia University ( Site 0056), Morgantown, West Virginia

HOSPITAL EVANGÉLICO DE CACHOEIRO DE ITAPEMIRIM ( Site 0307), Cachoeiro de Itapemirim, Espirito Santo

Hospital Sao Vicente de Paulo ( Site 0311), Passo Fundo, Rio Grande Do Sul

Instituto Joinvilense de Hematologia e Oncologia ( Site 0308), Joinville, Santa Catarina

Fundacao Faculdade Regional de Medicina de Sao Jose do Rio Preto ( Site 0305), Sao Jose do Rio Preto, Sao Paulo

Núcleo de Pesquisa Clínica da Rede São Camilo ( Site 0304), São Paulo, Sao Paulo

Nouvel Hôpital Civil (NHC) ( Site 1018), Strasbourg, Bas-Rhin

CHU Limoges CHU Dupuytren ( Site 1011), Limoges, Haute-Vienne

Hôpital Foch ( Site 1019), Suresnes, Hauts-de-Seine

Institut Regional du Cancer de Montpellier - ICM ( Site 1003), Montpellier, Herault

Centre Hospitalier Sud Réunion ( Site 1020), Saint-Pierre, La Reunion

Hopital Guillaume & Rene Laennec ( Site 1007), Saint-Herblain, Loire-Atlantique

Centre Hospitalier de Pau ( Site 1016), Pau, Pyrenees-Atlantiques

CHU de Rouen ( Site 1013), Rouen, Seine-Maritime

Hopital Cochin ( Site 1002), Paris, Not set

Centro de Investigaciones Clinicas de Latinoamerica S.A. - CELAN ( Site 0602), Guatemala, Not set

Clinica Privada Dr. Rixci Ramirez ( Site 0601), Guatemala, Not set

INTERVASC ( Site 0605), Guatemala, Not set

Grupo Angeles SA ( Site 0604), Guatemala, Not set

Centro Regional de Sub Especialidades Médicas SA ( Site 0600), Quetzaltenango, Not set

Bacs-Kiskun Megyei Korhaz-Onkoradiologiai Kozpont ( Site 1106), Kecskemét, Bacs-Kiskun

Petz Aladar Megyei Oktato Korhaz ( Site 1110), Gyor, Gyor-Moson-Sopron

Jasz Nagykun Szolnok Megyei Hetenyi Geza Korhaz Rendelointezet ( Site 1103), Szolnok, Jasz-Nagykun-Szolnok

Tudogyogyintezet Torokbalint ( Site 1105), Torokbalint, Pest

Veszprem Megyei Tudogyogyintezet ( Site 1108), Farkasgyepu, Veszprem

Zala Megyei Szent Rafael Korhaz ( Site 1111), Zalagerszeg, Zalaegerszeg

Semmelweis University-Pulmonológiai Klinika ( Site 1114), Budapest, Not set

Orszagos Koranyi Pulmonologiai Intezet ( Site 1104), Budapest, Not set

Fujita Health University Hospital ( Site 3007), Toyoake, Aichi

Ehime University Hospital ( Site 3005), Toon, Ehime

Kurume University Hospital ( Site 3006), Kurume, Fukuoka

National Hospital Organization Hokkaido Cancer Center ( Site 3014), Sapporo, Hokkaido

Kanazawa University Hospital ( Site 3004), Kanazawa, Ishikawa

Kanagawa Cardiovascular and Respiratory Center ( Site 3003), Yokohama, Kanagawa

Miyagi Cancer Center ( Site 3000), Natori, Miyagi

Sendai Kousei Hospital ( Site 3015), Sendai, Miyagi

Kurashiki Central Hospital ( Site 3013), Kurashiki, Okayama

Kansai Medical University Hospital ( Site 3016), Hirakata, Osaka

National Hospital Organization Kinki-chuo Chest Medical Center ( Site 3009), Sakai, Osaka

Osaka Medical and Pharmaceutical University Hospital ( Site 3017), Takatsuki, Osaka

Chiba University Hospital ( Site 3008), Chiba, Not set

National Hospital Organization Kyushu Medical Center ( Site 3001), Fukuoka, Not set

National Hospital Organization Kyushu Cancer Center ( Site 3002), Fukuoka, Not set

Okayama University Hospital ( Site 3012), Okayama, Not set

Osaka International Cancer Institute ( Site 3018), Osaka, Not set

Tokushima University Hospital ( Site 3019), Tokushima, Not set

Juntendo University Hospital ( Site 3011), Tokyo, Not set

Showa University Hospital ( Site 3010), Tokyo, Not set

Chungnam National University Hospital ( Site 2002), Daejeon, Chungnam

Chonnam National University Hwasun Hospital-Pulmonology ( Site 2000), Hwasun, Jeonranamdo

Korea University Guro Hospital ( Site 2003), Seoul, Not set

Hospital Nacional Carlos Alberto Seguin Escobedo ESSALUD ( Site 0704), Arequipa, Ariqipa

Clínica Peruano-Americana de Trujillo ( Site 0701), Trujillo, La Libertad

Oncosalud ( Site 0706), Lima, Muni Metro De Lima

Clinica Internacional Sede San Borja ( Site 0705), Lima, Not set

Instituto Nacional de Enfermedades Neoplasicas ( Site 0703), Lima, Not set

Hospital Nacional Cayetano Heredia ( Site 0700), Lima, Not set

Centrum Onkologii im prof Franciszka Lukaszczyka ( Site 1201), Bydgoszcz, Kujawsko-pomorskie

Mazowiecki Szpital Wojewódzki w Siedlcach-Siedleckie Centrum Onkologii ( Site 1206), Siedlce, Mazowieckie

Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy w Warszawie (, Warszawa, Mazowieckie

Centrum Pulmonologii i Torakochirurgii w Bystrej ( Site 1205), Bystra, Slaskie

Przychodnia Lekarska KOMED ( Site 1202), Konin, Wielkopolskie

Szpital Wojewodzki im. Mikolaja Kopernika ( Site 1200), Koszalin, Zachodniopomorskie

Cardiomed SRL Cluj-Napoca ( Site 1313), Cluj-Napoca, Cluj

Institutul Oncologic Prof.Dr. Ion Chiricuta Cluj-Napoca ( Site 1303), Cluj-Napoca, Cluj

SC Radiotherapy Center Cluj SRL ( Site 1307), Comuna Floresti, Cluj

S.C. Centrul de Oncologie Sf. Nectarie SRL ( Site 1304), Craiova, Dolj

Centrul de Oncologie Oncolab-Medical Oncology ( Site 1312), Craiova, Dolj

Spitalul Municipal Ploiesti ( Site 1308), Ploiesti, Prahova

Policlinica Oncomed SRL ( Site 1302), Timisoara, Timis

S.C.Focus Lab Plus S.R.L ( Site 1301), Bucuresti, Not set

Spitalul Universitar de Urgenta Bucuresti ( Site 1305), Bucuresti, Not set

SPBU Clinic of Advanced medical technologies n.a. N. I. Pirogov ( Site 1406), Saint-Petersburg, Sankt-Peterburg

National Medical Research Center of Oncology N.A. N.N. Petrov ( Site 1407), Saint-Petersburg, Sankt-Peterburg

Saint-Petersburg Scientific-Practical Center of Specialized Kinds of Medical Care (o) ( Site 1424), Saint-Petersburg, Sankt-Peterburg

Republican Clinical Oncology Dispensary-Chemotherapy #1 ( Site 1425), Kazan, Tatarstan, Respublika

SPb SBHI City Clinical Oncological Dispensary ( Site 1409), Sankt-Peterburg, Not set

Wits Clinical Research ( Site 1510), Johannesburg, Gauteng

Steve Biko Academic Hospital ( Site 1506), Pretoria, Gauteng

Marry Potter Oncology Centre ( Site 1502), Pretoria, Gauteng

Sandton Oncology Medical Group PTY LTD ( Site 1505), Sandton, Gauteng

Chris Hani Baragwanath Academic Hospital-Wits Clinical Research Bara ( Site 1513), Soweto, Gauteng

The Oncology Centre ( Site 1507), Durban, Limpopo

Cape Town Oncology Trials Pty Ltd ( Site 1500), Kraaifontein, Western Cape

Hospital Insular de Gran Canaria-Oncology ( Site 1604), Las Palmas de Gran Canaria, Las Palmas

H.U. Vall de Hebron ( Site 1600), Barcelona, Not set

Hospital Juan Ramon Jimenez ( Site 1602), Huelva, Not set

Hospital Universitario Lucus Augusti ( Site 1603), Lugo, Not set

Hospital Universitario La Paz ( Site 1601), Madrid, Not set

Changhua Christian Hospital ( Site 2104), Changhua, Not set

National Taiwan University Hospital Hsin-Chu Branch ( Site 2103), Hsinchu, Not set

Kaohsiung Medical University Chung-Ho Memorial Hospital ( Site 2107), Kaohsiung, Not set

National Cheng Kung University Hospital ( Site 2105), Tainan, Not set

National Taiwan University Hospital ( Site 2101), Taipei, Not set

Taipei Veterans General Hospital ( Site 2106), Taipei, Not set

Chang Gung Medical Foundation-Linkou Branch ( Site 2102), Taoyuan, Not set

Gulhane Egitim ve Arastirma Hastanesi ( Site 1704), Ankara, Not set

Ankara Sehir Hastanesi ( Site 1702), Ankara, Not set

TC Saglik Bakanligi Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi-oncology ( Site 1701), Istanbul, Not set

Ege Universitesi Tip Fakultesi Hastanesi ( Site 1703), Izmir, Not set

Inonu Universitesi Turgut Ozal Tip Merkezi ( Site 1707), Malatya, Not set

Medical Center Mriya Med-Service ( Site 1805), Kryvyi Rih, Dnipropetrovska Oblast

Communal non profit enterprise Regional Clinical Oncology Center ( Site 1806), Kharkiv, Kharkivska Oblast

Ukrainian Center of Tomotherapy ( Site 1807), Kropyvnytskyi, Kirovohradska Oblast

Medical Center Asklepion LLC ( Site 1804), Khodosivka, Kyivska Oblast

Municipal non-profit enterprise'Odesa Regional Clinical Hosp-Thoracic surgery department. ( Site 181, Odesa, Odeska Oblast

Kremenchuk Regional Oncology Center ( Site 1811), Kremenchuk, Poltavska Oblast

Kyiv City Clinical Oncology Centre ( Site 1809), Kyiv, Not set

Medical Center Dobrobut Clinic ( Site 1808), Kyiv, Not set

Conditions: Non-Small Cell Lung Cancer

Learn More ›

A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors

NCT02009449

Completed

This is a first-in-human, open-label, dose escalation study to evaluate the safety and tolerability of pegilodecakin in participants with advanced solid tumors, dosed daily subcutaneously as a monotherapy or in combination with chemotherapy or immunotherapy.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

11/13/2024

Locations: UCLA Medical Hematology & Oncology, Los Angeles, California +9 locations

Conditions: Melanoma, Prostate Cancer, Ovarian Cancer, Renal Cell Carcinoma, Colorectal Carcinoma, Pancreatic Carcinoma, Non-small Cell Lung Carcinoma, Solid Tumors, Breast Cancer

Learn More ›

Magnetic Resonance-Guided Hypofractionated Adaptive Radiation Therapy With Concurrent Chemotherapy and Consolidation Durvalumab for Inoperable Stage IIB, IIIA, and Select IIIB and IIIC Non-small Cell Lung Cancer

NCT03916419

Active Not Recruiting

Building upon the clinical experience of the investigators with the magnetic resonance (MR)-guided radiation therapy system and applying principals of hypofractionation toward the current treatment paradigm of concurrent chemoradiation and consolidation immunotherapy for locally advanced non-small cell lung cancer (NSCLC), this prospective, single-arm Phase II clinical trial with safety lead-in will test the feasibility and outcomes of this approach.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

11/12/2024

Locations: Washington University School of Medicine, Saint Louis, Missouri

Conditions: Stage IIB Non-Small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IIIC Non-Small Cell Lung Cancer

Learn More ›

Study of Olaparib Plus Pembrolizumab Versus Chemotherapy Plus Pembrolizumab After Induction With First-Line Chemotherapy Plus Pembrolizumab in Triple Negative Breast Cancer (TNBC) (MK-7339-009/KEYLYNK-009)

NCT04191135

Active Not Recruiting

The purpose of this study is to compare the efficacy of olaparib (MK-7339) plus pembrolizumab (MK-3475) with chemotherapy plus pembrolizumab after induction with first-line chemotherapy plus pembrolizumab in triple negative breast cancer (TNBC). The primary hypotheses are: 1. Olaparib plus pembrolizumab is superior to chemotherapy plus pembrolizumab with respect to progression-free survival (PFS). 2. Olaparib plus pembrolizumab is superior to chemotherapy plus pembrolizumab with respect to over... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

11/11/2024

Locations: Pacific Cancer Care ( Site 0142), Monterey, California +121 locations

Pacific Cancer Care ( Site 0142), Monterey, California

UCSF Helen Diller Family Comprehensive Cancer Center ( Site 0138), San Francisco, California

John Wayne Cancer Institute ( Site 0111), Santa Monica, California

St. Joseph Heritage Healthcare ( Site 0104), Santa Rosa, California

University of Miami Sylvester CC ( Site 0146), Miami, Florida

Georgia Cancer Center at Augusta University ( Site 0129), Augusta, Georgia

University of Chicago ( Site 0159), Chicago, Illinois

Massachusetts General Hospital ( Site 0155), Boston, Massachusetts

Henry Ford Health System ( Site 0103), Detroit, Michigan

Virginia Piper Cancer Institute ( Site 0157), Minneapolis, Minnesota

Memorial Sloan Kettering Cancer Center- Monmouth ( Site 0161), Middletown, New Jersey

MSKCC-Bergen ( Site 0162), Montvale, New Jersey

Memorial Sloan-Kettering Cancer Center at Commack ( Site 0160), Commack, New York

Memorial Sloan-Kettering Cancer Center ( Site 0156), New York, New York

Mercy Clinic Oncology and Hematology ( Site 0110), Oklahoma City, Oklahoma

The Center For Cancer And Blood Disorders ( Site 0151), Fort Worth, Texas

Texas Oncology-New Braunfels ( Site 0168), New Braunfels, Texas

Texas Oncology-San Antonio Northeast ( Site 0165), San Antonio, Texas

Texas Oncology-San Antonio Medical Center ( Site 0158), San Antonio, Texas

Texas Oncology - San Antonio Stone Oak ( Site 0166), San Antonio, Texas

Renovatio Clinical ( Site 0117), The Woodlands, Texas

Virginia Oncology Associates ( Site 0163), Newport News, Virginia

Virginia Oncology Associates ( Site 0153), Norfolk, Virginia

Virginia Oncology Associates ( Site 0164), Virginia Beach, Virginia

YVMH dba Virginia Mason Memorial/North Star Lodge Cancer Center ( Site 0128), Yakima, Washington

Princess Margaret Cancer Centre ( Site 0005), Toronto, Ontario

CSSS de Laval- Hopital de la Cite de la Sante ( Site 0011), Laval, Quebec

Centre Hospitalier de l Universite de Montreal - CHUM ( Site 0003), Montreal, Quebec

Jewish General Hospital ( Site 0010), Montreal, Quebec

McGill University Health Centre ( Site 0002), Montreal, Quebec

Centro Investigación del Cáncer James Lind ( Site 0510), Temuco, Araucania

IC La Serena Research ( Site 0511), La Serena, Coquimbo

Fundacion Arturo Lopez Perez ( Site 0500), Santiago, Region M. De Santiago

Pontificia Universidad Catolica de Chile ( Site 0501), Santiago, Region M. De Santiago

Oncocentro ( Site 0502), Vina del Mar, Valparaiso

Fundacion Colombiana de Cancerologia Clinica Vida ( Site 0601), Medellin, Antioquia

Clinica de la Costa Ltda. ( Site 0600), Barranquilla, Atlantico

Organizacion Clinica Bonnadona-Prevenir S.A.S. ( Site 0609), Barranquilla, Atlantico

Oncomedica S.A. ( Site 0606), Monteria, Cordoba

Fundacion Valle del Lili ( Site 0602), Cali, Valle Del Cauca

Hemato Oncologos S.A. ( Site 0603), Cali, Valle Del Cauca

Centre Francois Baclesse ( Site 1012), Caen, Calvados

CHU-Jean Minjoz ( Site 1013), Besancon, Doubs

Institut Claudius Regaud IUCT Oncopole ( Site 1001), Toulouse, Haute-Garonne

Centre de Cancerologie du Grand Montpellier ( Site 1009), Montpellier, Languedoc-Roussillon

CHR-METZ-THIONVILLE - Hopital de Mercy ( Site 1007), Metz, Moselle

Centre Jean Perrin ( Site 1003), Clermont-Ferrand Cedex 01, Puy-de-Dome

Centre Leon Berard ( Site 1018), Lyon, Rhone

Centre Henri Becquerel ( Site 1020), Rouen, Seine-Maritime

CHU Amiens Hopital Sud ( Site 1023), Amiens, Somme

Institut Gustave Roussy ( Site 1010), Villejuif, Val-de-Marne

Institut Sainte Catherine ( Site 1026), Avignon, Vaucluse

Hôpital Saint-Louis ( Site 1025), Paris, Not set

Universitaetsklinikum Mannheim GmbH ( Site 1213), Mannheim, Baden-Wurttemberg

Universitaetsklinikum Erlangen ( Site 1201), Erlangen, Bayern

Klinik und Poliklinik fuer Frauenheilkunde und Geburtshilfe ( Site 1200), Muenchen, Bayern

Hochwaldkrankenhaus Bad Nauheim ( Site 1211), Bad Nauheim, Hessen

Sana Klinikum Offenbach Klinik fuer Gynakologie und Geburtshilfe ( Site 1206), Offenbach am Main, Hessen

Gynaekologisch-onkologische Praxis Hannover ( Site 1207), Hannover, Niedersachsen

Gynaekologisches Zentrum-Schwerpunkt Gyn. Onkologie ( Site 1205), Bonn, Nordrhein-Westfalen

Universitaetsklinikum AoeR Duesseldorf ( Site 1210), Duesseldorf, Nordrhein-Westfalen

Kliniken Essen-Mitte ( Site 1215), Essen, Nordrhein-Westfalen

Frauenklinik St. Louise ( Site 1216), Paderborn, Nordrhein-Westfalen

Universitaetsklinikum Carl Gustav Carus ( Site 1203), Dresden, Sachsen

Bacs-Kiskun Megyei Korhaz-Onkoradiologiai Kozpont ( Site 1608), Kecskemét, Bacs-Kiskun

Pecsi Tudomanyegyetem Klinikai Kozpont ( Site 1607), Pecs, Baranya

Jasz Nagykun Szolnok Megyei Hetenyi Geza Korhaz Rendelointezet ( Site 1601), Szolnok, Jasz-Nagykun-Szolnok

Zala Megyei Szent Rafael Korhaz ( Site 1605), Zalaegerszeg, Zala

Orszagos Onkologiai Intezet ( Site 1602), Budapest, Not set

Debreceni Egyetem Klinikai Kozpont ( Site 1600), Debrecen, Not set

Somogy Megyei Kaposi Mor Oktato Korhaz ( Site 1604), Kaposvar, Not set

Cork University Hospital ( Site 0902), Cork, Not set

St Vincents University Hospital ( Site 0900), Dublin, Not set

Aichi Cancer Center Hospital ( Site 2202), Nagoya, Aichi

Hyogo College of Medicine Hospital ( Site 2203), Nishinomiya, Hyogo

Fukushima Medical University Hospital ( Site 2201), Fukushima, Not set

Hiroshima City Hiroshima Citizens Hospital ( Site 2204), Hiroshima, Not set

National Hospital Organization - Osaka National Hospital - Institute For Clinical Research (Site 2200), Osaka, Not set

National Cancer Center ( Site 2406), Goyang-si, Kyonggi-do

Seoul National University Bundang Hospital ( Site 2409), Seongnam-si, Kyonggi-do

Ajou University Hospital ( Site 2407), Suwon-si, Kyonggi-do

Kyungpook National University Chilgok Hospital ( Site 2402), Daegu, Taegu-Kwangyokshi

Gachon University Gil Medical Center ( Site 2408), Incheon, Not set

Seoul National University Hospital ( Site 2403), Seoul, Not set

Severance Hospital Yonsei University Health System ( Site 2401), Seoul, Not set

Asan Medical Center ( Site 2404), Seoul, Not set

Samsung Medical Center ( Site 2405), Seoul, Not set

Regionalny Szpital Specjalistyczny Latawiec ( Site 1917), Swidnica, Dolnoslaskie

Pratia MCM Krakow ( Site 1919), Krakow, Malopolskie

Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy w Warszawie (Site 1908), Warszawa, Mazowieckie

Szpital Morski im. PCK. Szpitale Pomorskie Sp. Z o.o ( Site 1913), Gdynia, Pomorskie

Narodowy Instytut Onkologii - Oddzial w Gliwicach ( Site 1912), Gliwice, Slaskie

Pleszewskie Centrum Medyczne w Pleszewie Sp. z o.o. ( Site 1909), Pleszew, Wielkopolskie

Hospital Universitario Reina Sofia ( Site 0705), Cordoba, Andalucia

Hospital General Arnau de Vilanova de Valencia ( Site 0706), Valencia, Valenciana, Comunitat

Instituto Oncologico Baselga.Hospital Quiron. ( Site 0707), Barcelona, Not set

Hospital Universitari Vall d Hebron ( Site 0701), Barcelona, Not set

Hospital Clinic I Provincial de Barcelona ( Site 0702), Barcelona, Not set

Clinica Universitaria Navarra - Madrid ( Site 0700), Madrid, Not set

Kaohsiung Chang Gung Memorial Hospital ( Site 2304), Kaohsiung, Not set

National Cheng Kung University Hospital ( Site 2303), Tainan, Not set

MacKay Memorial Hospital ( Site 2301), Taipei, Not set

Koo Foundation Sun Yat-Sen Cancer Center ( Site 2300), Taipei, Not set

China Medical University Hospital ( Site 2302), Taipei, Not set

Chernihiv Medical Center of Modern Oncology ( Site 1520), Chernihiv, Chernihivska Oblast

Dnipropetrovsk City Multidiscipline Clinical Hosp. 4 of DRC ( Site 1502), Dnipro, Dnipropetrovska Oblast

CI Krivorizhskiy oncology dispensery ( Site 1504), Kryviy Rih, Dnipropetrovska Oblast

MI Precarpathian Clinical Oncology Center ( Site 1506), Ivano-Frankivsk, Ivano-Frankivska Oblast

Grigoriev Institute for medical Radiology NAMS of Ukraine ( Site 1508), Kharkiv, Kharkivska Oblast

Communal non profit enterprise Regional Clinical Oncology Center ( Site 1512), Kharkiv, Kharkivska Oblast

SI-Zaytsev institute of general and urgent surgery-NAMS ( Site 1518), Kharkiv, Kharkivska Oblast

Medical Centre Consilium Medical ( Site 1514), Kyiv, Kyivska Oblast

Medical center of the Limited Liability Company Yulis ( Site 1517), Zaporizhzhia, Zaporizka Oblast

Medical Centre LLC Oncolife ( Site 1510), Zaporizhzhya, Zaporizka Oblast

Zhytomyr Regional Oncology Center ( Site 1515), Zhytomyr, Zhytomyrska Oblast

Medical Center Verum ( Site 1501), Kyiv, Not set

Raigmore Hospital ( Site 0915), Inverness, Highland

Blackpool Victoria Hospital ( Site 0921), Blackpool, Lancashire

North West Cancer Centre ( Site 0922), Londonderry, London, City Of

Barts Health NHS Trust ( Site 0912), London, London, City Of

Musgrove Park Hospital ( Site 0918), Taunton, Somerset

The Christie NHS Foundation Trust ( Site 0914), Manchester, Not set

Conditions: Triple Negative Breast Neoplasms

Learn More ›

MK-3475 Immunotherapy in Endometrial Carcinoma

NCT02630823

Completed

Due to the high expression of PD-L1 in endometrial cancers as well as in ovarian cancers which are molecularly similar to uterine serous cancers, using pembrolizumab should be beneficial in this patient population. Since the investigators are able to get a pre-treatment research- related endometrial biopsy as well as the surgical specimen post two cycles of pembrolizumab, the investigators will be able to evaluate the mechanism of action of this drug on the endometrial cancer tumor environment.

Gender:

FEMALE

Ages:

18 years and above

Trial Updated:

11/11/2024

Locations: Washington University School of Medicine, Saint Louis, Missouri

Conditions: Endometrial Cancer, Endometrial Carcinoma, Neoplasms, Endometrial

Learn More ›

Dose Escalation and Expansion Study of GSK3359609 in Participants With Selected Advanced Solid Tumors (INDUCE-1)

NCT02723955

Completed

GSK3359609 is an anti-Inducible T cell Co-Stimulator (ICOS) receptor agonist antibody intended for the treatment of cancers of different histology. This is a first-time-in-human (FTIH), open-label, multicenter study designed to investigate the safety, pharmacology, and preliminary antitumor activity in participants with selected, advanced or recurrent solid tumors with the aim to establish recommended dose(s) of GSK3359609 for further exploration as monotherapy and in combination with pembrolizu... Read More

Gender:

ALL

Ages:

Between 18 years and 93 years

Trial Updated:

11/08/2024

Locations: GSK Investigational Site, Duarte, California +27 locations

GSK Investigational Site, Duarte, California

GSK Investigational Site, Los Angeles, California

GSK Investigational Site, Sarasota, Florida

GSK Investigational Site, New York, New York

GSK Investigational Site, Oklahoma City, Oklahoma

GSK Investigational Site, Philadelphia, Pennsylvania

GSK Investigational Site, Nashville, Tennessee

GSK Investigational Site, Heidelberg, Victoria

GSK Investigational Site, Melbourne, Victoria

GSK Investigational Site, Nedlands, Western Australia

GSK Investigational Site, Toronto, Ontario

GSK Investigational Site, Shnghai, Not set

GSK Investigational Site, Bordeaux Cedex, Not set

GSK Investigational Site, Lyon cedex 08, Not set

GSK Investigational Site, Paris, Not set

GSK Investigational Site, Villejuif cedex, Not set

GSK Investigational Site, Siena, Toscana

GSK Investigational Site, Chiba, Not set

GSK Investigational Site, Osaka, Not set

GSK Investigational Site, Tokyo, Not set

GSK Investigational Site, Amsterdam, Not set

GSK Investigational Site, Barcelona, Not set

GSK Investigational Site, Madrid, Not set

GSK Investigational Site, MÃ¡ga, Not set

GSK Investigational Site, Sevilla, Not set

Conditions: Neoplasms

Learn More ›

A Study of the Efficacy and Safety of Atezolizumab Plus Chemotherapy for Patients With Early Relapsing Recurrent Triple-Negative Breast Cancer

NCT03371017

Completed

This study will evaluate the efficacy and safety of atezolizumab plus chemotherapy compared with placebo plus chemotherapy in patients with inoperable recurrent triple-negative breast cancer (TNBC).

Gender:

ALL

Ages:

18 years and above

Trial Updated:

11/07/2024

Locations: Florida Cancer Specialists - Fort Myers (Broadway), Fort Myers, Florida +135 locations

Florida Cancer Specialists - Fort Myers (Broadway), Fort Myers, Florida

Florida Cancer Specialists & Research Institute, Saint Petersburg, Florida

The Valley Hospital, Paramus, New Jersey

Magee-Woman's Hospital; UPMC Pinnacle Cancer Center, Harrisburg, Pennsylvania

Magee-Woman's Hospital, Pittsburgh, Pennsylvania

SCRI Oncology Partners, Nashville, Tennessee

Inova Schar Cancer Institute, Falls Church, Virginia

Fundación CENIT para la Investigación en Neurociencias, Buenos Aires, Not set

Instituto de Oncología de Rosario, Rosario, Not set

Hospital Provincial del Centenario, Rosario, Not set

University Clinical Center of the Republic of Srpska, Banja Luka, Not set

Clinical center University of Sarajevo, Sarajevo, Not set

Oncocentro Serviços Medicos E Hospitalares Ltda, Fortaleza, CE

Hospital Araujo Jorge; Departamento de Ginecologia E Mama, Goiania, GO

Hospital do Cancer de Pernambuco - HCP, Recife, PE

Hospital Sao Vicente de Paulo, Passo Fundo, RS

Hospital Nossa Senhora da Conceicao, Porto Alegre, RS

Centro de Oncologia de Santa Catarina LTDA, Chapeco, SC

Instituto de Pesquisa Grupo NotreDame Intermedica, Sao Paulo, SP

Hospital Perola Byington, Sao Paulo, SP

Núcleo de Pesquisa São Camilo; ONCOLOGIA CLINICA / QUIMIOTERAPIA, Sao Paulo, SP

Patagonia Research, Puerto Montt, Not set

Bradford Hill Centro de Investigaciones Clinicas, Recoleta, Not set

Fundacion Arturo Lopez Perez, Santiago, Not set

Clinica Vespucio, Santiago, Not set

James Lind Centro de Investigación Del Cáncer, Temuco, Not set

ONCOCENTRO APYS; Oncología, Vina Del Mar, Not set

Cancer Hospital , Chinese Academy of Medical, Beijing City, Not set

Peking University People's Hospital, Beijing, Not set

Beijing Cancer Hospital, Beijing, Not set

the First Affiliated Hospital of Bengbu Medical College, Bengbu City, Not set

Jilin Cancer Hospital, Changchun, Not set

The First Affiliated Hospital, Chongqing Medical University, Chongqing, Not set

Fujian Medical University Union Hospital, Fuzhou City, Not set

Sun Yat-sen Memorial Hospital, Guangzhou, Not set

Sir Run Run Shaw Hospital Zhejiang University, Hangzhou City, Not set

Harbin Medical University Cancer Hospital, Harbin, Not set

Shandong Cancer Hospital, Jinan, Not set

The First Affiliated Hospital Of Jinzhou Medical University, Jinzhou City, Not set

Jiangsu Province Hospital, Nanjing, Not set

The Affiliated Hospital of Medical College Qingdao University, Qingdao, Not set

Fudan University Shanghai Cancer Center; Medical Oncology, Shanghai City, Not set

Hebei Medical University Fourth Hospital;(Tumor Hospital of Hebei Province), Shijiazhuang, Not set

Shanxi Province Cancer Hospital, Taiyuan City, Not set

Tianjin Cancer Hospital, Tianjin, Not set

The First Affiliated Hospital of The Fourth Military Medical University (Xijing Hospital), Xi'an, Not set

Zhejiang Cancer Hospital, Zhejiang, Not set

Hospital Hermanos Ameijeiras, La Habana, Not set

Instituto Nacional de Oncología y Radiología (INOR), La Habana, Not set

Helsinki University Central Hospital; Dept of Oncology, Helsinki, Not set

Tampere University Hospital; Dept of Oncology, Tampere, Not set

Centre Georges-François Lecler; Ctr de Lutte Contre le Canc, Dijon, Not set

Centre Leon Berard; Oncologie Genetique, Lyon, Not set

Institut Paoli-Calmettes; Oncologie Medicale 1, Marseille Cedex 09, Not set

Centre Régional de Lutte Contre Le Cancer Val D'aurelle Paul Lamarque, Montpellier, Not set

Centre Eugene Marquis; Service d'oncologie, Rennes, Not set

INSTITUT CURIE_SITE PARIS - Service d'Oncologie Médicale., St Cloud, Not set

Centre Alexis Vautrin; Oncologie Medicale, Vandoeuvre-les-nancy, Not set

IGR, Villejuif, Not set

Universitätsklinikum "Carl Gustav Carus"; Frauenheilkunde und Geburtshilfe, Dresden, Not set

Klinikum Essen-Mitte Ev. Huyssens-Stiftung / Knappschafts GmbH; Klinik für Senologie / Brustzentrum, Essen, Not set

Varisano Klinikum Frankfurt Höchst GmbH, Frankfurt, Not set

Universitätsklinikum Halle (Saale); Universitätsklinik Und Poliklinik Für Gynäkologie, Halle, Not set

Medizinische Hochschule Hannover, Klinik für Frauenheilkunde und Geburtshilfe, Hannover, Not set

Nationales Centrum für Tumorerkrankungen (NCT) ; Gyn. Onk. Frauenklinik; Uniklinikum Heidelberg, Heidelberg, Not set

Medizinisches Zentrum für Hämatologie und Onkologie, München, Not set

Szent Margit Hospital, Budapest, Not set

Orszagos Onkologiai Intezet; B Belgyogyaszati Osztaly, Budapest, Not set

Budapesti Uzsoki Utcai Kórház, Budapest, Not set

Borsod-Abauj-Zemplen Megyei Korhaz es Egyetemi Oktato Korhaz;Sugarterapias Klinikai Onkologiai Intez, Miskolc, Not set

Pécsi Tudományegyetem; Klinikai Központ Onkoterápiás Intézet, Pécs, Not set

Istituto Nazionale per lo Studio e la Cura dei Tumori Fondazione G. Pascale, Napoli, Campania

Azienda Ospedaliero Universitaria San Martino, Genova, Liguria

Ospedale San Raffaele S.r.l., Milano, Lombardia

Irccs Istituto Europeo Di Oncologia (IEO); Ricerca Di Senologia Medica, Milano, Lombardia

Ospedale San Gerardo, Monza, Lombardia

Fondazione Del Piemonte Per L'oncologia Ircc Di Candiolo; Dipartimento Oncologico, Candiolo, Piemonte

Ospedale Antonio Perrino; Oncologia Medica, Brindisi, Puglia

Azienda Ospedaliero-Universitaria Careggi; SOD Radioterapia, Firenze, Toscana

IRCCS Istituto Oncologico Veneto (IOV); Oncologia Medica Seconda, Padova, Veneto

Kazakh Scientific Research Institution Of Oncology and Radiology, Almaty, Not set

Seoul National University Bundang Hospital, Seongnam-si, Not set

Seoul National University Hospital, Seoul, Not set

Severance Hospital, Yonsei University Health System, Seoul, Not set

Asan Medical Center, Seoul, Not set

Samsung Medical Center, Seoul, Not set

Centro Medico Dalinde, Cdmx, Mexico CITY (federal District)

CENEIT Oncologicos; DENTRO DE CONDOMINIO SAN FRANCISCO, Mexico City, Not set

Instituto Nacional de Cancerologia; Oncology, Mexico City, Not set

Clinical Center of Montenegro; Clinic for Oncology and Radiotherapy, Podgorica, Not set

Centre Hospitalier Universitaire Hassan II, FES, Not set

Centre Hospitalier Universitaire Mohamed VI; Oncologie-Hématologie, Marrakech, Not set

Clinique specialise Menara; Oncology Medical, Marrakech, Not set

Institut National D'oncologie Sidi Med Benabdellah, Rabat, Not set

The Panama Clinic, Panama, Not set

Instituto Nacional de Enfermedades Neoplasicas, Lima, Not set

?wi?tokrzyskie Centrum Onkologii; Dzia? Chemioterapii, Kielce, Not set

Narodowy Inst.Onkologii im.Sklodowskiej-Curie Panstw.Inst.Bad; Klinika Nowtw.Piersi i Chir.Rekonstr, Warszawa, Not set

Hospital de Santa Maria; Servico de Oncologia Medica, Lisboa, Not set

Centro Hospitalar do Porto ? Hospital de Santo António; Oncologia, Porto, Not set

Moscow City Oncology Hospital #62, Moscovskaya Oblast, Moskovskaja Oblast

Moscow Clinical Scientific Center, Moscow, Moskovskaja Oblast

FSBI "National Medical Research Center of Oncology N.N. Blokhin?, Moscow, Moskovskaja Oblast

City Clinical Oncology Dispensary, SPb SBIH CCOD, Saint-Petersburg, Sankt Petersburg

FBI "Scientific Research Institute of Oncology n. a. N. N. Petrov", Saint-Petersburg, Sankt Petersburg

Private Healthcare Institution Clinical Hospital RZhD Medicine, St. Petersburg, Sankt Petersburg

Institute of Oncology and Radiology of Serbia, Belgrade, Not set

University Hospital Medical Center Bezanijska kosa, Belgrade, Not set

Clinical Centre Nis, Clinic for Oncology, Nis, Not set

Oncology Institute of Vojvodina, Sremska Kamenica, Not set

National Cancer Centre; Medical Oncology, Singapore, Not set

Wits Clinical Research; Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, Not set

Medical Oncology Centre of Rosebank; Oncology, Johannesburg, Not set

Private Oncology Centre, Pretoria, Not set

Hospital de Cruces; Servicio de Oncologia, Bilbao, Vizcaya

Hospital Universitari Vall d'Hebron; Oncology, Barcelona, Not set

Hospital General Universitario Gregorio Marañon; Servicio de Oncologia, Madrid, Not set

Hospital Ramon y Cajal; Servicio de Oncologia, Madrid, Not set

Hospital Clinico Universitario Virgen de la Victoria; Servicio de Oncologia, Malaga, Not set

Hospital Clínico Universitario de Valencia; Servicio de Oncología, Valencia, Not set

Hacettepe University Medical Faculty; Department of Internal Medicine, Ankara, Not set

Ankara Oncology Hospital; Medical Oncology Department, Ankara, Not set

Ege University Medical Faculty; Medical Oncology Department, Bornova, ?zm?r, Not set

Trakya Universitesi Tip Fakultesi, Medikal Onkoloji Bilim Dali, Balkan Yerleskesi, Edirne, Not set

Medipol University Medical Faculty; Oncology Department, Istanbul, Not set

Marmara University Pendik Training and Research Hospital; Medikal Onkoloji, Istanbul, Not set

Necmettin Erbakan University Meram Medical Faculty ; Internal Diseases, Konya, Not set

Velindre Cancer Centre; Oncology Dept, Cardiff, Not set

University Hospital Coventry, Coventry, Not set

Western General Hospital; Edinburgh Cancer Center, Edinburgh, Not set

Royal Lancaster Infirmary, Morecambe Bay Hospitals Nhs Trust, Lancaster, Not set

Barts, London, Not set

Guys and St Thomas NHS Foundation Trust, Guys Hospital, London, Not set

Christie Hospital NHS Trust, Manchester, Not set

Mount Vernon Cancer Centre, Northwood, Not set

Royal Stoke University Hospital, Stoke-on-Trent, Not set

Conditions: Triple Negative Breast Neoplasms

Learn More ›

Neoadjuvant Pembrolizumab + Decitabine Followed by Std Neoadj Chemo for Locally Advanced HER2- Breast Ca

NCT02957968

Active Not Recruiting

This study is a 2-cohort, open-label, multicenter, phase 2 study of a short course of immunotherapy consisting of sequential decitabine followed by pembrolizumab administered prior to a standard neoadjuvant chemotherapy regimen for patients with locally advanced HER2-negative breast cancer. The primary efficacy objective is to determine if the immunotherapy increases the presence and percentage of tumor and/or stromal area of infiltrating lymphocytes prior to initiation of standard neoadjuvant c... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

11/07/2024

Locations: St. Elizabeth Healthcare, Edgewood, Kentucky +4 locations

Conditions: Breast Adenocarcinoma, Estrogen Receptor- Negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2/Neu Negative, Invasive Breast Carcinoma, Progesterone Receptor Negative, Progesterone Receptor Positive Tumor, Stage II Breast Cancer, Stage IIA Breast Cancer, Stage IIB Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Triple-negative Breast Carcinoma

Learn More ›

Chemotherapy and Pelvic Radiation Therapy With or Without Additional Chemotherapy in Treating Patients With High-Risk Early-Stage Cervical Cancer After Radical Hysterectomy

NCT00980954

Active Not Recruiting

RATIONALE: Drugs used in chemotherapy, such as cisplatin, paclitaxel, and carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Radiation therapy uses high-energy x-rays to kill tumor cells. It is not yet known whether chemotherapy and radiation therapy are more effective when given with or without additional chemotherapy in treating cervical cancer. PURPOSE: This randomized phase III trial is studying chemotherapy... Read More

Gender:

FEMALE

Ages:

18 years and above

Trial Updated:

11/07/2024

Locations: University of Alabama at Birmingham, Birmingham, Alabama +124 locations

University of Alabama at Birmingham, Birmingham, Alabama

Providence Hospital, Mobile, Alabama

Providence Alaska Medical Center, Anchorage, Alaska

Arizona Center for Cancer Care-Peoria, Peoria, Arizona

Saint Joseph's Hospital and Medical Center, Phoenix, Arizona

Providence Saint Joseph Medical Center/Disney Family Cancer Center, Burbank, California

Mercy San Juan Medical Center, Carmichael, California

City of Hope Medical Center, Duarte, California

Saint Joseph Hospital - Orange, Orange, California

Pomona Valley Hospital Medical Center, Pomona, California

Mercy Cancer Center, Sacramento, California

Mercy General Hospital Radiation Oncology Center, Sacramento, California

Saint Helena Hospital, Saint Helena, California

University of California At San Diego, San Diego, California

Penrose-Saint Francis Healthcare, Colorado Springs, Colorado

Hartford Hospital, Hartford, Connecticut

The Hospital of Central Connecticut, New Britain, Connecticut

University of Miami Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach, Florida

Memorial Healthcare System - Joe DiMaggio Children's Hospital, Hollywood, Florida

Jackson Memorial Hospital-Holtz Children's Hospital, Miami, Florida

University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida

Baptist Hospital of Miami, Miami, Florida

Florida Hospital, Orlando, Florida

Grady Health System, Atlanta, Georgia

Northside Hospital, Atlanta, Georgia

Northeast Georgia Medical Center, Gainesville, Georgia

Memorial Health University Medical Center, Savannah, Georgia

Saint Joseph's-Candler Health System, Savannah, Georgia

Queen's Medical Center, Honolulu, Hawaii

University of Hawaii, Honolulu, Hawaii

Saint Alphonsus Regional Medical Center, Boise, Idaho

Northwestern University, Chicago, Illinois

Rush University Medical Center, Chicago, Illinois

OSF Saint Francis Medical Center, Peoria, Illinois

Saint Vincent Anderson Regional Hospital/Cancer Center, Anderson, Indiana

Saint Francis Hospital and Health Centers, Beech Grove, Indiana

Franciscan Saint Margaret Health-Hammond Campus, Hammond, Indiana

Franciscan Saint Francis Health-Indianapolis, Indianapolis, Indiana

Michiana Hematology Oncology PC-Mishawaka, Mishawaka, Indiana

University of Iowa Hospitals and Clinics, Iowa City, Iowa

Mercy Medical Center - North Iowa, Mason City, Iowa

University of Kansas Medical Center, Kansas City, Kansas

Kansas City Cancer Centers-Southwest, Overland Park, Kansas

Via Christi Regional Medical Center, Wichita, Kansas

University of Maryland/Greenebaum Cancer Center, Baltimore, Maryland

Greater Baltimore Medical Center, Baltimore, Maryland

Sinai Hospital of Baltimore, Baltimore, Maryland

Central Maryland Radiation Oncology in Howard County, Columbia, Maryland

Holy Cross Hospital, Silver Spring, Maryland

Hickman Cancer Center, Adrian, Michigan

Saint John Hospital and Medical Center, Detroit, Michigan

West Michigan Cancer Center, Kalamazoo, Michigan

Saint Joseph Mercy Port Huron, Port Huron, Michigan

Saint John Macomb-Oakland Hospital, Warren, Michigan

Abbott-Northwestern Hospital, Minneapolis, Minnesota

Mayo Clinic, Rochester, Minnesota

University of Mississippi Medical Center, Jackson, Mississippi

Kansas City Cancer Center - South, Kansas City, Missouri

Kansas City Cancer Centers - North, Kansas City, Missouri

Kansas City Cancer Center-Lee's Summit, Lee's Summit, Missouri

Phelps County Regional Medical Center, Rolla, Missouri

Saint John's Mercy Medical Center, Saint Louis, Missouri

Mercy Hospital Springfield, Springfield, Missouri

CoxHealth South Hospital, Springfield, Missouri

Nebraska Methodist Hospital, Omaha, Nebraska

The Nebraska Medical Center, Omaha, Nebraska

Elliot Hospital, Manchester, New Hampshire

Cooper Hospital University Medical Center, Camden, New Jersey

Morristown Memorial Hospital, Morristown, New Jersey

Fox Chase Cancer Center at Virtua Memorial Hospital of Burlington County, Mount Holly, New Jersey

UMDNJ - New Jersey Medical School, Newark, New Jersey

MD Anderson Cancer Center at Cooper-Voorhees, Voorhees, New Jersey

Montefiore Medical Center-Weiler Division, Bronx, New York

Montefiore Medical Center, Bronx, New York

State University of New York Downstate Medical Center, Brooklyn, New York

Memorial Sloan-Kettering Cancer Center, New York, New York

Highland Hospital, Rochester, New York

University of Rochester, Rochester, New York

Carolinas Medical Center, Charlotte, North Carolina

Summa Akron City Hospital/Cooper Cancer Center, Akron, Ohio

Akron General Medical Center, Akron, Ohio

Summa Barberton Hospital, Barberton, Ohio

University of Cincinnati, Cincinnati, Ohio

Case Western Reserve University, Cleveland, Ohio

Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center, Columbus, Ohio

Summa Health Center at Lake Medina, Medina, Ohio

UHHS-Chagrin Highlands Medical Center, Orange Village, Ohio

Southern Ohio Medical Center, Portsmouth, Ohio

Robinson Radiation Oncology, Ravenna, Ohio

Cancer Care Center, Incorporated, Salem, Ohio

Ireland Cancer Center at Firelands Regional Medical Center, Sandusky, Ohio

Flower Hospital, Sylvania, Ohio

University of Toledo, Toledo, Ohio

UHHS-Westlake Medical Center, Westlake, Ohio

Cancer Treatment Center, Wooster, Ohio

University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma

Providence Portland Medical Center, Portland, Oregon

Providence Saint Vincent Medical Center, Portland, Oregon

Delaware County Memorial Hospital, Drexel Hill, Pennsylvania

Reading Hospital, West Reading, Pennsylvania

Lankenau Hospital, Wynnewood, Pennsylvania

Women and Infants Hospital, Providence, Rhode Island

Rapid City Regional Hospital, Rapid City, South Dakota

Sanford Cancer Center-Oncology Clinic, Sioux Falls, South Dakota

University of Tennessee - Knoxville, Knoxville, Tennessee

University of Texas Southwestern Medical Center, Dallas, Texas

M D Anderson Cancer Center, Houston, Texas

Methodist Hospital, Houston, Texas

Intermountain Medical Center, Murray, Utah

McKay-Dee Hospital Center, Ogden, Utah

Dixie Medical Center Regional Cancer Center, Saint George, Utah

Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah

Seattle Cancer Care Alliance, Seattle, Washington

North Star Lodge Cancer Center at Yakima Valley Memorial Hospital, Yakima, Washington

Wheeling Hospital, Wheeling, West Virginia

Saint Vincent Hospital, Green Bay, Wisconsin

Aurora Saint Luke's Medical Center, Milwaukee, Wisconsin

Froedtert and the Medical College of Wisconsin, Milwaukee, Wisconsin

Aurora West Allis Medical Center, West Allis, Wisconsin

McGill University Department of Oncology, Montreal, Quebec

Pamela Youde Nethersole Eastern Hospital, Chai Wan, Not set

Seoul National University Bundang Hospital, Seongnam City, Kyeonggi-do

Seoul National University Hospital, Seoul, Not set

Gangnam Severance Hospital, Seoul, Not set

Korea Cancer Center Hospital, Seoul, Not set

Conditions: Cervical Cancer

Learn More ›

Browse by State

Carboplatin treatment options in Alabama

Carboplatin treatment options in Alaska

Carboplatin treatment options in Arizona

Carboplatin treatment options in Arkansas

Carboplatin treatment options in California

Carboplatin treatment options in Colorado

Carboplatin treatment options in Connecticut

Carboplatin treatment options in Delaware

Carboplatin treatment options in District of Columbia

Carboplatin treatment options in Florida

Carboplatin treatment options in Georgia

Carboplatin treatment options in Hawaii

Carboplatin treatment options in Idaho

Carboplatin treatment options in Illinois

Carboplatin treatment options in Indiana

Carboplatin treatment options in Iowa

Carboplatin treatment options in Kansas

Carboplatin treatment options in Kentucky

Carboplatin treatment options in Louisiana

Carboplatin treatment options in Maine

Carboplatin treatment options in Montana

Carboplatin treatment options in Nebraska

Carboplatin treatment options in Nevada

Carboplatin treatment options in New Hampshire

Carboplatin treatment options in New Jersey

Carboplatin treatment options in New Mexico

Carboplatin treatment options in New York

Carboplatin treatment options in North Carolina

Carboplatin treatment options in North Dakota

Carboplatin treatment options in Ohio

Carboplatin treatment options in Oklahoma

Carboplatin treatment options in Oregon

Carboplatin treatment options in Maryland

Carboplatin treatment options in Massachusetts

Carboplatin treatment options in Michigan

Carboplatin treatment options in Minnesota

Carboplatin treatment options in Mississippi

Carboplatin treatment options in Missouri

Carboplatin treatment options in Pennsylvania

Carboplatin treatment options in Rhode Island

Carboplatin treatment options in South Carolina

Carboplatin treatment options in South Dakota

Carboplatin treatment options in Tennessee

Carboplatin treatment options in Texas

Carboplatin treatment options in Utah

Carboplatin treatment options in Vermont

Carboplatin treatment options in Virginia

Carboplatin treatment options in Washington

Carboplatin treatment options in West Virginia

Carboplatin treatment options in Wisconsin

Carboplatin treatment options in Wyoming